Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2026-01-01 @ 12:57 AM
Study NCT ID:
NCT01820559
Status:
COMPLETED
Last Update Posted:
2013-05-24
First Post:
2013-03-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Eslicarbazepine Acetate as Preventive Therapy for Subjects With Migraine
Sponsor:
Bial - Portela C S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04
Start Date Type:
None
Primary Completion Date:
2010-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-06
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-26
First Submit QC Date:
None
Study First Post Date:
2013-03-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-04-05
Results First Submit QC Date:
None
Results First Post Date:
2013-05-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-04-05
Last Update Post Date:
2013-05-24
Last Update Post Date Type:
ESTIMATED